http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2581050-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f5ee54b402cf117455e911d5d1949a5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C06B49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-08
filingDate 2015-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86f371e4f472ec1c53e2bc4e78276ecf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3867c8142d1689089bcc3401105c438c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca5653e5e4958acda8027e2fd945982
publicationDate 2016-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2581050-C1
titleOfInvention Bis(fluorodinythromethyl-onn-azoxy)azoxyfurazan and preparation method thereof
abstract FIELD: chemistry. n SUBSTANCE: present invention relates to organic chemistry, namely to poly nitro compounds derivatives chemistry, specifically to bis(fluorodinythromethyl-ONN-azoxy) azoxyfurazane of formula (I). Method of producing a compound of formula (I) consists in that bis(dinythromethyl-ONN-azoxy)azoxyfurazane of formula (II) is treated with KOH and formed corresponding dipotassium salt reacts with xenon difluoride (XeF 2 ). n EFFECT: high-power compound, characterised by positive oxygen balance (OB) higher enthalpy of formation ( Δ H f o ) n and higher density (d) for use as fusible explosive or fusible base for powerful explosive compounds. n 2 cl, 1 tbl, 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2747110-C1
priorityDate 2015-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2536041-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408120365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415998843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458418124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9794126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426698549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425001370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID533871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466305423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419818127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14896652
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452703164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419729191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID110624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454620584

Total number of triples: 43.